FilingSEC EDGAR8-K
Tempest Therapeutics Appoints Nicholas Rossettos as New CFO
· SEC accepted
StageManagement Change
Filing content
Tempest Therapeutics has appointed Nicholas Rossettos as the new CFO, effective September 1, 2026, following the resignation of Justin Trojanowski.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…